SCHEMBL4050340

SCHEMBL4050340

CCOC(=O)Oc1cc2c(s1)-c1cc(OCCCN(C)C)ccc1Oc1ccccc1-2

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 2/20 0.42
CACNA1H O95180 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
PDK2 Q15119 2/20 0.39
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 5/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
MAOB P27338 2/20 0.36
BCHE P06276 1/20 0.36
MAOA P21397 1/20 0.36
ACHE P22303 1/20 0.36
TYMS P04818 1/20 0.36
ESR1 P03372 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
LTA4H P09960 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4041725 0.94 CACNA1B (0.41) CACNA1BCACNA1HHDAC3HDAC1HDAC2
SCHEMBL4045987 0.89 HDAC3 (0.41) CACNA1BCACNA1HHDAC3HDAC1HDAC2
SCHEMBL4045889 0.85 CACNA1B (0.43) CACNA1BCACNA1HHDAC3HDAC1HDAC2
SCHEMBL4047340 0.84 PPARG (0.44) ALDH1A1MAOBMAOAESR1
SCHEMBL4046658 0.83 CACNA1B (0.44) CACNA1BCACNA1HHDAC3HDAC1HDAC2
SCHEMBL6204224 0.81 TYMS (0.37) ALDH1A1KDM4ESMN1; SMN2TYMS
SCHEMBL4046122 0.80 CACNA1B (0.43) CACNA1BCACNA1HHDAC3HDAC1HDAC2
SCHEMBL4044883 0.79 CACNA1B (0.43) CACNA1BCACNA1HHDAC3HDAC1HDAC2
SCHEMBL5414630 0.78 CACNA1B (0.40) CACNA1BCACNA1HHDAC3HDAC1HDAC2
SCHEMBL4043160 0.78 PPARG (0.43) ALDH1A1SMN1; SMN2MAOBMAOAESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603921-B1 THIADIBENZOAZULENE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES GLAXOSMITHKLINE ZAGREB (HR) 2009-06-17 EP claimed